These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2898213)

  • 1. Exacerbation of psychosis after discontinuation of carbamazepine treatment.
    Heh CW; Sramek J; Herrera J; Costa J
    Am J Psychiatry; 1988 Jul; 145(7):878-9. PubMed ID: 2898213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute psychosis associated with abrupt withdrawal of carbamazepine following intoxication.
    Darbar D; Connachie AM; Jones AM; Newton RW
    Br J Clin Pract; 1996 Sep; 50(6):350-1. PubMed ID: 8983329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders.
    Okuma T; Yamashita I; Takahashi R; Itoh H; Otsuki S; Watanabe S; Sarai K; Hazama H; Inanaga K
    Acta Psychiatr Scand; 1989 Sep; 80(3):250-9. PubMed ID: 2573234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of carbamazepine in negative symptom schizophrenia.
    Nachshoni T; Levin Y; Levy A; Kritz A; Neumann M
    Biol Psychiatry; 1994 Jan; 35(1):22-6. PubMed ID: 7909450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.
    Shiovitz TM; Welke TL; Tigel PD; Anand R; Hartman RD; Sramek JJ; Kurtz NM; Cutler NR
    Schizophr Bull; 1996; 22(4):591-5. PubMed ID: 8938913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manic and psychotic symptoms following risperidone withdrawal in a schizophrenic patient.
    Lane HY; Chang WH
    J Clin Psychiatry; 1998 Nov; 59(11):620-1. PubMed ID: 9862609
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
    Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M
    Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a rare psychopathological phenomenon: tactile hallucinations and the delusional other.
    Heveling T; Emrich HM; Dietrich DE
    Eur Psychiatry; 2004 Sep; 19(6):387-8. PubMed ID: 15363483
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacologic treatment of schizophrenia: a progress report.
    Donaldson SR; Gelenberg AJ; Baldessarini RJ
    Schizophr Bull; 1983; 9(4):504-27. PubMed ID: 6140750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis.
    Sultan S; Chouinard G; Beaudry P
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):431-8. PubMed ID: 1972802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.
    Angelopoulos P; Markopoulou M; Kyamidis K; Bobotas K
    Gen Hosp Psychiatry; 2008; 30(5):482-4. PubMed ID: 18774435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine adjunct for nonresponsive psychosis with prior hallucinogenic abuse.
    Scher M; Neppe V
    J Nerv Ment Dis; 1989 Dec; 177(12):755-7. PubMed ID: 2574229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine as an adjunct of antipsychotic therapy.
    Dose M; Apelt S; Emrich HM
    Psychiatry Res; 1987 Dec; 22(4):303-10. PubMed ID: 3324137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.